Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.73
-0.27 (-0.82%)
Aug 14, 2025, 12:03 PM - Market open
Immunocore Holdings Employees
Immunocore Holdings had 493 employees as of December 31, 2024. The number of employees decreased by 4 or -0.80% compared to the previous year.
Employees
493
Change (1Y)
-4
Growth (1Y)
-0.80%
Revenue / Employee
$722,404
Profits / Employee
-$41,201
Market Cap
1.65B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 493 | -4 | -0.80% |
| Dec 31, 2023 | 497 | 89 | 21.81% |
| Dec 31, 2022 | 408 | 84 | 25.93% |
| Dec 31, 2021 | 324 | 33 | 11.34% |
| Dec 31, 2020 | 291 | -168 | -36.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMCR News
- 5 days ago - Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Immunocore reports second quarter financial results and provides a business update - GlobeNewsWire
- 14 days ago - Immunocore to report second quarter 2025 financial results and host call on August 7, 2025 - GlobeNewsWire
- 6 weeks ago - Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS Regions - GlobeNewsWire
- 2 months ago - Immunocore to present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Immunocore reports first quarter financial results and provides a business update - GlobeNewsWire
- 4 months ago - Immunocore to present at upcoming investor conferences - GlobeNewsWire
- 5 months ago - Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 - GlobeNewsWire